Viridian Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $81.06 | $2.72 B | -49.3 | 130 | $110.32 M |
 BPMC
|
Blueprint Medicines Corporation | $94.65 | $6.47 B | -21.48 | 638 | $249.38 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $56.58 | $3.53 B | -11.86 | 290 | $4.01 M |
 CYTK
|
Cytokinetics, Incorporated | $51.94 | $6.05 B | -9.78 | 423 | $7.53 M |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 ETNB
|
89bio, Inc. | $9.04 | $796.91 M | -4.05 | 70 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $39.16 | $2.47 B | -23.59 | 136 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
|
INZY
|
Inozyme Pharma, Inc. | $4.30 | $286.39 M | -3.43 | 59 | $0 |
 KURA
|
Kura Oncology, Inc. | $17.50 | $1.66 B | -10.03 | 142 | $0 |
|
MRUS
|
Merus N.V. | $51.56 | $3.50 B | -19.38 | 172 | $43.95 M |
 NUVL
|
Nuvalent, Inc. | $89.05 | $5.11 B | -32.72 | 115 | $0 |
 PCVX
|
Vaxcyte, Inc. | $105.50 | $7.72 B | -16.54 | 254 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $14.44 | $672.63 M | -3.9 | 166 | $1.58 M |
|
PTGX
|
Protagonist Therapeutics, Inc. | $45.94 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $12.26 | $485.18 M | -2.44 | 331 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $55.82 | $6.66 B | -10.51 | 443 | $11.58 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.85 | $1.66 B | -6.02 | 184 | $0 |
 TERN
|
Terns Pharmaceuticals, Inc. | $7.06 | $462.44 M | -5.67 | 66 | $0 |